JPS5933224A - 全血、組織及び、生存哺乳動物細胞を含む成分を保存するための嫌気的方法 - Google Patents
全血、組織及び、生存哺乳動物細胞を含む成分を保存するための嫌気的方法Info
- Publication number
- JPS5933224A JPS5933224A JP57141598A JP14159882A JPS5933224A JP S5933224 A JPS5933224 A JP S5933224A JP 57141598 A JP57141598 A JP 57141598A JP 14159882 A JP14159882 A JP 14159882A JP S5933224 A JPS5933224 A JP S5933224A
- Authority
- JP
- Japan
- Prior art keywords
- starch
- product
- biological
- blood
- fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004369 blood Anatomy 0.000 title claims description 49
- 239000008280 blood Substances 0.000 title claims description 49
- 238000000034 method Methods 0.000 title claims description 42
- 241000124008 Mammalia Species 0.000 title claims description 13
- 229920000881 Modified starch Polymers 0.000 claims description 39
- 235000019426 modified starch Nutrition 0.000 claims description 39
- 238000003860 storage Methods 0.000 claims description 22
- 229920001612 Hydroxyethyl starch Polymers 0.000 claims description 21
- 229920002472 Starch Polymers 0.000 claims description 21
- 229940050526 hydroxyethylstarch Drugs 0.000 claims description 21
- 235000019698 starch Nutrition 0.000 claims description 21
- 239000008107 starch Substances 0.000 claims description 21
- 239000003431 cross linking reagent Substances 0.000 claims description 16
- 210000003743 erythrocyte Anatomy 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 210000000265 leukocyte Anatomy 0.000 claims description 14
- 239000007789 gas Substances 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 12
- 239000012620 biological material Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 8
- 239000003146 anticoagulant agent Substances 0.000 claims description 8
- 229940127219 anticoagulant drug Drugs 0.000 claims description 8
- 230000002000 scavenging effect Effects 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 5
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 5
- 210000002381 plasma Anatomy 0.000 claims description 5
- 108060003951 Immunoglobulin Proteins 0.000 claims description 4
- 239000004020 conductor Substances 0.000 claims description 4
- 102000018358 immunoglobulin Human genes 0.000 claims description 4
- 238000001879 gelation Methods 0.000 claims description 3
- 239000001341 hydroxy propyl starch Substances 0.000 claims description 3
- 235000013828 hydroxypropyl starch Nutrition 0.000 claims description 3
- 239000011261 inert gas Substances 0.000 claims description 3
- 230000004083 survival effect Effects 0.000 claims description 3
- 238000010926 purge Methods 0.000 claims description 2
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims 3
- 239000008223 sterile water Substances 0.000 claims 3
- 102000006395 Globulins Human genes 0.000 claims 1
- 108010044091 Globulins Proteins 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000003463 adsorbent Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 238000006386 neutralization reaction Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 235000020985 whole grains Nutrition 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 21
- 210000001519 tissue Anatomy 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 239000000463 material Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 238000004321 preservation Methods 0.000 description 10
- 239000000427 antigen Substances 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- -1 tissues Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000008081 blood perfusion Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- VEMLQICWTSVKQH-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;propane-1,2,3-triol Chemical compound OCC(O)CO.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O VEMLQICWTSVKQH-BTVCFUMJSA-N 0.000 description 1
- IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 description 1
- KYARBIJYVGJZLB-UHFFFAOYSA-N 7-amino-4-hydroxy-2-naphthalenesulfonic acid Chemical compound OC1=CC(S(O)(=O)=O)=CC2=CC(N)=CC=C21 KYARBIJYVGJZLB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- UNPLRYRWJLTVAE-UHFFFAOYSA-N Cloperastine hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 UNPLRYRWJLTVAE-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 235000016936 Dendrocalamus strictus Nutrition 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102100035129 Forkhead box protein K2 Human genes 0.000 description 1
- 101710088031 Forkhead box protein K2 Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 108010047620 Phytohemagglutinins Proteins 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 241000405961 Scomberomorus regalis Species 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004555 blood preservation Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013400 design of experiment Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052743 krypton Inorganic materials 0.000 description 1
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 1
- 235000021190 leftovers Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000011824 nuclear material Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000001885 phytohemagglutinin Effects 0.000 description 1
- 239000003058 plasma substitute Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24413781A | 1981-03-16 | 1981-03-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5933224A true JPS5933224A (ja) | 1984-02-23 |
| JPH0557244B2 JPH0557244B2 (enExample) | 1993-08-23 |
Family
ID=22921506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57141598A Granted JPS5933224A (ja) | 1981-03-16 | 1982-08-14 | 全血、組織及び、生存哺乳動物細胞を含む成分を保存するための嫌気的方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0061277B1 (enExample) |
| JP (1) | JPS5933224A (enExample) |
| AU (1) | AU559805B2 (enExample) |
| CA (1) | CA1182753A (enExample) |
| DE (1) | DE3272969D1 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014051141A1 (ja) * | 2012-09-28 | 2014-04-03 | 積水メディカル株式会社 | 無希釈系イムノクロマトグラフ法試薬において希釈試料を測定するための添加物 |
| JP2016508120A (ja) * | 2012-11-30 | 2016-03-17 | アドバンスド プリザベイションズ テクノロジーズ リミテッド ライアビリティー カンパニー | 赤血球の保存方法 |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879283A (en) * | 1985-10-03 | 1989-11-07 | Wisconsin Alumni Research Foundation | Solution for the preservation of organs |
| GB9021325D0 (en) * | 1990-10-01 | 1990-11-14 | Geistlich Soehne Ag | Chemical composition |
| AUPQ906300A0 (en) * | 2000-07-28 | 2000-08-24 | Monash University | Method of preserving cells and uses thereof |
| CA2542426A1 (en) * | 2003-10-22 | 2005-05-06 | Fred Hutchinson Cancer Research Center | Methods, compositions and devices for inducing stasis in cells |
| PT1879599E (pt) | 2005-04-20 | 2014-01-23 | Hutchinson Fred Cancer Res | Métodos, composições e artigos de fabrico para aumentar a capacidade de sobrevivência de células, tecidos, órgãos, e organismos |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3523938A (en) * | 1967-12-13 | 1970-08-11 | American Hospital Supply Corp | Starch plasma expanders and process of preparation |
| US3937821A (en) * | 1971-08-21 | 1976-02-10 | Kyorin Seiyaku Kabushiki Kaisha | Plasma substitute including artificial starch and method for the preparation thereof |
| US3912715A (en) * | 1972-03-31 | 1975-10-14 | Nat Starch Chem Corp | Process for preparing novel cationic flocculating agents and paper made there-with |
| GB1514720A (en) * | 1974-10-07 | 1978-06-21 | Secr Defence | Preparation of hydroxyethyl starch |
| US4004975A (en) * | 1975-12-30 | 1977-01-25 | The United States Of America As Represented By The Secretary Of The Navy | Method of isolating and cryopreserving human white cells from whole blood |
| DE2634539C2 (de) * | 1976-07-31 | 1983-08-25 | Hoechst Ag, 6230 Frankfurt | Verfahren zur Herstellung von saugfähigen, modifizierten Stärkeethern und deren Verwendung |
| US4153585A (en) * | 1978-05-08 | 1979-05-08 | National Starch And Chemical Corporation | Starch ether derivatives and process for the preparation thereof |
| DE2908436A1 (de) * | 1979-03-05 | 1980-09-25 | Fresenius Chem Pharm Ind | Kolloidales gefrierschutzmittel |
-
1982
- 1982-03-15 EP EP82301307A patent/EP0061277B1/en not_active Expired
- 1982-03-15 DE DE8282301307T patent/DE3272969D1/de not_active Expired
- 1982-08-12 CA CA000409277A patent/CA1182753A/en not_active Expired
- 1982-08-13 AU AU87173/82A patent/AU559805B2/en not_active Ceased
- 1982-08-14 JP JP57141598A patent/JPS5933224A/ja active Granted
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014051141A1 (ja) * | 2012-09-28 | 2014-04-03 | 積水メディカル株式会社 | 無希釈系イムノクロマトグラフ法試薬において希釈試料を測定するための添加物 |
| JP5562508B1 (ja) * | 2012-09-28 | 2014-07-30 | 積水メディカル株式会社 | 無希釈系イムノクロマトグラフ法試薬において希釈試料を測定するための添加物 |
| JP2016508120A (ja) * | 2012-11-30 | 2016-03-17 | アドバンスド プリザベイションズ テクノロジーズ リミテッド ライアビリティー カンパニー | 赤血球の保存方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0061277A3 (en) | 1983-04-13 |
| DE3272969D1 (en) | 1986-10-09 |
| EP0061277A2 (en) | 1982-09-29 |
| EP0061277B1 (en) | 1986-09-03 |
| AU8717382A (en) | 1984-02-16 |
| AU559805B2 (en) | 1987-03-19 |
| CA1182753A (en) | 1985-02-19 |
| JPH0557244B2 (enExample) | 1993-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4473552A (en) | Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells | |
| US4007087A (en) | Sperm fractionation and storage | |
| Bloom et al. | Factor VIII on the vascular intima: possible importance in haemostasis and thrombosis | |
| Granger et al. | Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines | |
| Hubel | Parameters of cell freezing: implications for the cryopreservation of stem cells | |
| FI113694B (fi) | Menetelmä ja pakkausrakenne viljeltyjen kudosekvivalenttien kylmäsäilytykseen ja varastoimiseen | |
| ES2260809T3 (es) | Metodo para la determinacion del sexo de una progenie mamifera. | |
| JPS60500400A (ja) | 組織培養培地 | |
| JPH07507304A (ja) | 製薬的に許容しうる固定乾燥ヒト血液血小板 | |
| White | Exocytosis of secretory organelles from blood platelets incubated with cationic polypeptides | |
| JPS5829714A (ja) | 血清不含およびミトゲン不含ｔ細胞生長因子およびその製造法 | |
| Vaughan et al. | Interactions of macrophages and erythrocytes | |
| JPH06503466A (ja) | 細胞分離発明 | |
| Smith et al. | Protein synthesis in enucleated eggs of Rana pipiens | |
| Triplett et al. | Observations on some immune reactions of the sipunculid worm Dendrostomum zostericolum | |
| DE69329340T2 (de) | Aufbewahren von stammzellen | |
| RU95120155A (ru) | Лекарственный препарат иммунокоррегирующего действия на основе клеточной суспензии и способ лечения сахарного диабета с использованием этого препарата | |
| JPH11512924A (ja) | 細胞の処理 | |
| EP0061277B1 (en) | Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells | |
| JP3819862B2 (ja) | 多細胞生物の組織の常温乾燥保存方法 | |
| WO1991009521A1 (en) | Identification process and related method for use in preparing a biological sample | |
| Hors et al. | A simplified method for freezing lymphocytes in nitrogen vapors | |
| CN1014228B (zh) | 医用深低温保存容器 | |
| Correa et al. | Quantitative and qualitative characteristics of frozen-thawed bovine spermatozoa recovered via a conventional and a standardized swim-up technique | |
| CN100482785C (zh) | 一种人卵母细胞的贮存方法 |